San Francisco, 14 Dec 2018 - “Proteomics Market Analysis By Product (Instruments, Reagents, Services), By Technology (Microarray, X-Ray Crystallography, Spectroscopy, Chromatography, Protein Fractionation Systems, Electrophoresis, Surface Plasma Resonance Systems), By Application (Drug Discovery, Clinical Diagnosis), By Region And Segment Forecasts To 2024,”According to a report by Grand View Research, Inc., global proteomics market is anticipated to value USD 24.8 billion by 2024. Growing requirement for better and timely diagnosis of fatal diseases such as diabetes and cancer is anticipated to propel demand for proteomics. It can provide essential information related to broad range of diseases and support diagnosis for better treatment.
Rising cases of chronic diseases such as diabetes, cardiovascular disorders, and cancer owing to unhealthy lifestyle and sudden climatic changes can augment market growth. Favorable regulations and government policies are expected to research and development in proteomics. This, in turn can augment growth of market over next few years. Continual technological advancements in the field such as multiple reaction monitoring, which can quantify proteins in cerebrospinal fluid for detection of later stages of multiple sclerosis can augment demand for proteomics. This, in turn can stimulate growth of market during the forecast period (2013 to 2024).
Access Full Report On Proteomics Market: www.grandviewresearch.com/industry-analysis/proteomics-market
The proteomics market can be segregated on the basis of product, technology, application, and region. Based on product, the market can be categorized into instruments, reagents, and services. In 2015, regents segment dominated the market and accounted for fast growth attributed to wide spread research in academic institutes. In addition, high frequency usage of kits, chemicals, reagent, and strips for various analysis of various biological samples can fuel growth. The segment is expected to witness substantial growth at CAGR of 8.5% during the forecast period.
Similarly, introduction of technologically advanced instruments such as 2D electrophoresis protein analyzers can augment growth of market. In addition, instruments such as electrophoresis instruments and biochip analyzers can be used for quantification of proteins. Moreover, rising demand for fast, user-friendly, cost-effective, and accurate devices can fuel growth of segment.
Based on technology, the market can be classified into microarray instruments, x-ray crystallography, spectroscopy, chromatography, protein fractionation systems, electrophoresis, and surface plasma resonance systems. Large scale analysis of proteins through techniques such as x-ray crystallography, protein fractionation systems, microarray, and surface plasma resonance can provide view of molecular and cellular functions that can give access to overall information of complex processes in living systems. Moreover, increasing importance of such studies for targeted diagnosis and treatment can leads to rise in demand for proteomics during the forecast period.
In 2015, microarray segment dominated the market and accounted for revenue equivalent to USD 5.6 billion. Ability of microarrays to produce more information from small samples can fuel market growth. They can give advantage of label-free detection, direct, and absolute quantification, and full imprint of proteins.
Moreover, spectroscopy segment is predicted to grow fast over the forecast period. Introduction of novel technologies coupled with rising demand for accurate and rapid devices can fuel analysis of proteins. This, in turn can fuel growth of segment.
Based on application, the market can be clinical diagnosis, drug discovery, and others. Clinical diagnosis are expected to foresee significant growth attributed to wide range of application that can include host-pathogen interaction, disease biomarker discovery, personalized medicines, study of disease pathogenesis, and identification of drug target. In addition, introduction of technologically advanced instruments, increasing awareness on newer diagnostic techniques, and growing use of personalized medicines can fuel market growth.
Regional segmentation includes Europe, North America, Asia Pacific, Latin America, and Middle East & Africa (MEA). In 2015, North America dominated the market and accounted for 40% market share. Prevalence of superior healthcare infrastructure, large base of target population, and presence of key market players in the region can fuel market growth. In addition, sufficient funding from local governments for R&D can foster growth of market in the region.
In Asia Pacific, the market is predicted to witness significant growth at CAGR of 12%. Developing countries such as India and China are expected to have higher chances of growth during the forecast period. In addition, increasing funding from government and private organizations for research and growth in proteomics based outsourcing to the region can augment growth of market.
Some of the leading companies offering proteomics are Bio-Rad Laboratories; Thermo Fisher Scientific, Inc.; Roche Diagnostics; Illumina, Inc.; and GE Healthcare. Most companies are expected to be involved in R&D activities for development of instrument-compatible kits. This is expected to be their major strategic initiative to sustain market position.
Grand View Research has segmented the proteomics market on the basis of product, technology, application, and region:
Proteomics Market Product Outlook, by Revenue (USD Million, 2013 & 2024)
- Instruments
- Reagents
- Services
Proteomics Market Technology Outlook, by Revenue (USD Million, 2013 & 2024)
- Microarray Instruments
- X-Ray Crystallography
- Spectroscopy
- Chromatography
- Protein Fractionation Systems
- Electrophoresis
- Surface Plasma Resonance Systems
Proteomics Market Application Outlook, by Revenue (USD Million, 2013 & 2024)
- Drug Discovery
- Clinical Diagnosis
- Others
Proteomics Market Regional Outlook, by Revenue (USD Million, 2015 & 2024)
- North America
- US.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- MEA
- South Africa
Browse Press Release of this Report: www.grandviewresearch.com/press-release/global-proteomics-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment